PETX– Aratana Therepeutics Inc is a pet therapeutics company which manufactures and distributes bio pharmaceutical products for pets. The stock rose 5% during after-hours yesterday.

PETX- Aratana Therepeutics Inc

Fundamentals Previously closed at 5.19
Day’s high 6.17
Day’s low 4.43
P/E ratio NA
EPS -2.44


Analysts opinion PETX has been granted its first FDA approval for Galliprant which controls the pain and inflammation with Osteoarthritis in dogs. Analysts have a consensus target price of $11.83 for the stock. The shares surged intraday upto its resistance at $6.17 and closed at 5.19. If the resistance levels are crossed, the stock may see a share price of $10.
Sentiments Due to the news, the stock rose 5% yesterday and is expected to be bullish.
Social Media Pulse The stock has 100% higher chatter than usual.

ESLT – Elbit Systems Ltd is an Israel-based defense, homeland security and commercial aviation company.

ESLT – Elbit Systems Ltd

Fundamentals Previously closed at 90.26
Day’s high 90.54
Day’s low 89.98
P/E ratio 21
EPS 4.30


Analyst opinion ESLT reported its Q4 and FY2015 earnings today. For Q4, it reported revenues of $886.6 Million, compared $850.3 million in the Prior Year Q4. It reported a GAAP gross profit of $253.3 million for Q4.  Revenues for FY 2015 saw a rise, at $3107.6 million with a profit of $897.1 million.
Sentiments The news is expected to have strong positive impact on the stock price. Sentiments are expected to be bullish for the stock today.
Social Media Pulse The stock has 100% higher social chatter than usual.



Disclaimer: This blog contains an aggregated view of analysts and opinions by the author. Do not consider this as financial advice. See


Leave a Reply

Your email address will not be published. Required fields are marked *